Alcon receives European Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery
(Thomson Reuters ONE via COMTEX) — Novartis International AG / Alcon receives European Approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
– AcrySof(R) IQ Aspheric Intraocular Lens (IOL) with UltraSertTM Pre-loaded Delivery System helps to maintain the integrity of the incision while facilitating smooth, consistent delivery of the IOL
– Following recent European approval of trifocal presbyopia-correcting IOL, single-use delivery system further expands the Alcon portfolio for cataract surgery
Basel, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof(R) IQ Aspheric IOL with the UltraSertTM Pre-loaded Delivery System for patients undergoing cataract surgery. The new delivery system combines the control of a manually loaded device with the safety and convenience of a disposable, pre-loaded injector to optimize implantation of the AcrySof IQ Aspheric IOL. This approval follows the recent CE Mark for Alcon’s trifocal presbyopia-correcting AcrySof IOL which was received in mid-June. More than three million cataract surgeries are performed each year in Europe.
“Alcon is committed to advancing cataract surgery through the continuous development of new technologies and processes,” said Franck Leveiller, PhD., Alcon Surgical Head of Research & Development. “Every detail of the UltraSert Pre-loaded Delivery System has been engineered with the needs of surgeons, technicians and the outcomes for their patients in mind. By simplifying the device preparation and maximizing surgeon control in a single-use system, we have cleared the path for more streamlined procedures and potentially improved patient outcomes.”……….
Source: Market Watch